Silence Therapeutics reported 2.77M in Cost of Sales for its fiscal quarter ending in September of 2024.


Cost Of Sales Change Date
AstraZeneca USD 2.47B 232M Jun/2025
Autolus Therapeutics Ltd 24.91M 6.96M Jun/2025
Hikma Pharmaceutical USD 895M 82M Dec/2024
Novartis USD 3.32B 95M Jun/2025
Roche Holding CHF 4.13B 393.5M Dec/2024
Silence Therapeutics 2.77M 136K Sep/2024